読み込み中
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface; and the Omnipod Insulin Management System. It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy. The company sells its products to end-users through the pharmacy channel; and independent distributors. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
前日終値
$135.28
+$0.81 · +0.60%
日中の時刻はETです。市場データは遅延する場合があります。
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface; and the Omnipod Insulin Management System. It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy. The company sells its products to end-users through the pharmacy channel; and independent distributors. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
日中レンジ
現在 $135.28
52週レンジ
現在 $135.28
日中の時刻はETです。市場データは遅延する場合があります。
GoAI スコア
中立
バリュエーション
84
大幅な割安
センチメント
70
強気
リスク
60
やや高いリスク
モメンタム
31
弱含み
GoAIの詳細リサーチ
詳しい根拠、カタリスト、リスクを確認できます。
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface; and the Omnipod Insulin Management System. It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy. The company sells its products to end-users through the pharmacy channel; and independent distributors. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
日中レンジ
現在 $135.28
52週レンジ
現在 $135.28
利用可能な期間全体で報告されたマージン。
売上高
営業利益
純利益
| 指標（USD） | 2025年度 | 2024年度 | 2023年度 | 2022年度 | 2021年度 |
|---|---|---|---|---|---|
| 売上高 | 27.08億 USD | 20.72億 USD | 16.97億 USD | 13.05億 USD | 10.99億 USD |
| 売上原価 | 7.68億 USD | 6.26億 USD | 5.37億 USD | 5億 USD | 3.47億 USD |
| 粗利益 | 19.4億 USD | 14.46億 USD | 11.6億 USD | 8.06億 USD | 7.52億 USD |
| 研究開発 | 3.01億 USD | 2.2億 USD | 2.05億 USD | 1.8億 USD | 1.6億 USD |
| 販売・一般管理 | 11.65億 USD | 9.17億 USD | 7.35億 USD | 5.88億 USD | 4.66億 USD |
| 営業費用 | 14.66億 USD | 11.37億 USD | 9.4億 USD | 7.68億 USD | 6.26億 USD |
| 受取利息 | 3470万 USD | 3950万 USD | 2860万 USD | 930万 USD | 50万 USD |
| 支払利息 | 7970万 USD | 4270万 USD | 3620万 USD | 3600万 USD | 6170万 USD |
| 減価償却費と償却費 | 9040万 USD | 8080万 USD | 7280万 USD | 6320万 USD | 5740万 USD |
| 営業利益 | 4.74億 USD | 3.09億 USD | 2.2億 USD | 3760万 USD | 1.26億 USD |
| 純利益 | 2.47億 USD | 4.18億 USD | 2.06億 USD | 460万 USD | 1680万 USD |
会社概要が更新されました 2026年10月10日.
直近の発表実績
直近の発表実績
第三者のアナリスト予想は変更される場合があり、GoAIの推奨ではありません。
平均目標
$182.35
上昇余地（34.79%）価格履歴は利用できません
最高：$235平均：$182.35最低：$144この株式へのエクスポージャーを報告している上場投資信託です。
State Street SPDR S&P 500 ETF1557.T181.37億0.01%129.34兆 JPY0.09%￥122,850+0.12%
Vanguard Morningstar Total Stock Market ETFVTI3.28億0.01%2.3兆 USD0.03%$381.94+0.63%
Vanguard S&P 500 ETFVOO2.73億0.02%1.8兆 USD0.03%$715.59+0.61%
Vanguard Morningstar Small-Cap ETFVB2.37億0.13%1853億 USD0.03%$289.48+0.64%
Invesco S&P 500 Equal Weight ETFRSP1.93億0.20%967.55億 USD0.20%$213.04+0.55%
Vanguard Morningstar Small-Cap Growth ETFVBK1.36億0.30%447億 USD0.05%$344.74+1.22%
iShares Core S&P 500 ETFIVV1.24億0.01%8927.95億 USD0.03%$781.97+0.60%
State Street SPDR S&P 500 ETFSPY1.15億0.01%8172億 USD0.09%$778.57+0.60%State Street SPDR S&P 500 ETF1557.TVanguard Morningstar Total Stock Market ETFVTIVanguard S&P 500 ETFVOOVanguard Morningstar Small-Cap ETFVBInvesco S&P 500 Equal Weight ETFRSPVanguard Morningstar Small-Cap Growth ETFVBKiShares Core S&P 500 ETFIVVState Street SPDR S&P 500 ETFSPYAIが生成した遅延市場データを、情報提供および教育目的で掲載しています。投資助言ではありません。
